Federated Hermes’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-190,034	Closed	-$1.94M	–	2406
2020 Q3	$1.94M	Buy	190,034 +12,487	+7%	+$127K	﹤0.01%	1001
2020 Q2	$2.65M	Buy	+177,547	New	+$2.65M	0.01%	889